Pieper Steven
SEC insider (Form 3/4/5 filer). CIK 0001875714. Officer at Xeris Biopharma Holdings, Inc. (XERS). 16 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in CHICAGO, IL.
Companies Pieper Steven has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Officer, See Remarks
Pieper Steven
CIK: 0001875714
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xeris Biopharma Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Oct 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect5K shares at avg. $9.41$47K - Sep 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect5K shares at avg. $8.50$43K - Aug 12, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect5K shares at avg. $8.50$43K - Jul 7, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect27.6K shares at avg. $8.52$235K - Jul 6, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect17.4K shares at avg. $8.50$148K - Mar 5, 2026XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect14K shares at avg. $5.93$83K - Mar 5, 2026XERS
Xeris Biopharma Holdings, Inc.
ExerciseDirect27.9K shares at avg. $4.09$114K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect111.8K shares at avg. $7.36$823K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect27.3K shares at avg. $7.36$201K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax PaymentDirect66.5K shares at avg. $7.36$489K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 5,000 | $9.41 | $47,037 | Direct |
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 5,000 | $8.50 | $42,500 | Direct |
| Aug 12, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 5,000 | $8.50 | $42,500 | Direct |
| Jul 7, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 27,600 | $8.52 | $235,276 | Direct |
| Jul 6, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 17,400 | $8.50 | $147,900 | Direct |
| Mar 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 14,036 | $5.93 | $83,233 | Direct |
| Mar 5, 2026 | XERS Xeris Biopharma Holdings, Inc. | Exercise | 27,891 | $4.09 | $114,074 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 111,765 | $7.36 | $822,590 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 27,319 | $7.36 | $201,068 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment | 66,450 | $7.36 | $489,072 | Direct |
1-10 of 16 transactions